In recognition of 20 years of #WLAD, what are your hopes for the next 20 years in #lymphoma research? Hear from Michelle Boyer, Global Head of Product Development, Lymphoma, at Roche, who shares her hopes for the future of lymphoma care and discusses the importance of #HonestTalk between patients and healthcare teams to help define treatment goals and improve outcomes. 👇
Hakkımızda
Roche, insanların yaşamlarını iyileştirmek için bilimde ileri gitmeye odaklanmasıyla farmasötikte ve tanılamada küresel bir öncüdür. Farmasötik ile tanılamanın tek çatı altındaki birleşik gücü, Roche’u kişiselleştirilmiş sağlık hizmetlerinde lider yapmıştır ki - bu, her hastaya doğru tedaviyi mümkün olan en iyi şekilde uyarlamayı amaçlayan bir stratejidir. Roche; onkoloji, immünoloji, bulaşıcı hastalıklar, göz hekimliği ve merkezi sinir sistemi hastalıklarında gerçek anlamda farklılaştırılmış ilaçlarla dünyanın en büyük biyoteknoloji şirketidir. Roche aynı zamanda in vitro tanılamada ve doku esaslı kanser tanılamasında dünya lideridir ve diyabet yönetiminde ön sıralardadır. 1896’da kurulan Roche, hastalıkları önlemenin, tanılamanın ve tedavi etmenin daha iyi yollarını aramaya devam etmekte ve topluma sürdürülebilir bir katkı yapmaktadır. Şirket ayrıca tüm ilgili paydaşlarla birlikte çalışarak hastaların tıbbi yeniliklere erişimini geliştirmeyi de amaçlamaktadır. Roche tarafından geliştirilmiş olan otuz ilaç, Dünya Sağlık Örgütü Elzem İlaçlar Model Listelerine alınmıştır ki bunlar arasında hayat kurtaran antibiyotikler, sıtma ilaçları ve kanser ilaçları da vardır. Roche, Dow Jones Sürdürülebilirlik Endeksleri (DJSI) tarafından art arda dokuz yıl Farmasötik, Biyoteknoloji ve Yaşam Bilimleri Sektöründe sürdürülebilirlikte Grup Lideri olarak tanınmıştır. Genel merkezi İsviçre’nin Basel kentinde bulunan Roche Grubu, 100’den fazla ülkede faaldir ve 2017’de dünya genelinde yaklaşık 94,000 kişiyi istihdam etmiştir. Roche, 2017’de ARGE’ye 10.4 milyar İsviçre frangı yatırım yapmış ve 53.3 milyar İsviçre frangı satış beyan etmiştir. Amerika Birleşik Devletleri’nde bulunan Genentech, Roche Grubu’nun bütünüyle sahibi olduğu bir üyesidir. Roche, Japonya’daki Chugai Pharmaceutical’ın çoğunluk hisselerine sahiptir. Daha fazla bilgi için lütfen http://www.roche.com/careers sayfasına bakın. #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- Web Sitesi
-
http://www.roche.com/
Roche için harici link
- Sektör
- Biyoteknoloji Araştırması
- Şirket büyüklüğü
- 10.001+ çalışan
- Genel Merkez
- Switzerland 🇨🇭
- Türü
- Halka Açık Şirket
- Uzmanlık Alanları
- biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data ve Science
Konum
Roche şirketindeki çalışanlar
Güncellemeler
-
Watch our Cancer Dialogue video to hear Charles Fuchs’ and Luis Paz-Ares' thoughts on the most pressing challenges to overcome in cancer care: http://spkl.io/6049f1aUd Despite significant advances in oncology over the last few years, there are still many areas where we need to deepen our scientific understanding, drive innovation and improve outcomes for patients. In our first episode of Cancer Dialogue, Charles Fuchs and Luis Paz-Ares come together at #ESMO24 to share their thoughts on advancing research, further improving cancer care and making a meaningful difference to patients’ lives.
-
At Roche, we harness cutting-edge technology and scientific expertise to deliver targeted innovations and enhance early detection. Together with partners like Union for International Cancer Control (UICC) we are developing scalable, sustainable solutions to improve outcomes for cancer patients worldwide. Curious to know more? Read the reflections Michael Oberreiter and Dr Cary Adams on the future of cancer care and innovation. #WCC2024 #InnovationInCancerCare #Roche #Partnerships #HealthInnovation
-
The United Nations General Assembly (UNGA) is taking place this month as global leaders meet to shape solutions for our future. As leaders discuss important global health topics like antimicrobial resistance and health security, they will need to consider new approaches to investing in healthcare in general 💡 Tamara Schudel VP & Head of Global Policy at Roche, will be at #UNGA speaking to global health and policy leaders about the need to reconsider health as a strategic investment, rather than a cost. You can learn more about the investment case for health, why we must tackle antimicrobial resistance through a multi-sectoral approach and more here. 👉 http://spkl.io/6043fEvD5 #UNGA #Roche #HealthcareInnovation
-
In our first edition of ‘Cancer Dialogue’, Charles Fuchs, Global Head of Oncology & Hematology Drug Development at Roche and Genentech, sits down with Luis Paz-Ares, Head of Medical Oncology Department Hospital Universitario 12 de Octubre, at #ESMO24 to explore the biggest and most urgent challenges in oncology. Watch Luis answer and the full conversation here: http://spkl.io/6042fDQGG
-
Are you ready to be part of something bigger than yourself❓ Join our amazing community where your passions and talents can make a real difference. Whether it's through groundbreaking projects, meaningful connections, or unforgettable experiences, there's a place for you here. 🔍 Discover new opportunities. 🤝 Connect with like-minded individuals. 🌍 Make an impact. Don’t just watch — become a part of something greater. Your journey starts now. 🚀 Find more information about Community & Culture at Roche: https://lnkd.in/dmHgZRWQ
-
What sparks your interest when you think of oncology innovation and the future of cancer care? Learn from leading oncology experts as we explore some of the key developments in the space and what they may mean for cancer care in our new video series ‘Cancer Dialogue’. Stay tuned over #ESMO24 as we share the first edition of the series. What would you like to see discussed in the ‘Cancer Dialogue’ series? Comment below and have your say!
-
Reflecting on #ERSCongress, we are both inspired by the progress in the field and reminded of the significant burden respiratory conditions like chronic obstructive pulmonary disease (COPD) pose. Bringing together the minds behind the research and initiatives, the #ERSCongress is powering change in respiratory health. Through collaboration with leaders across the respiratory community, we can expand our understanding of complex diseases, such as #COPD and bring positive change for the millions affected. To learn more, click here: http://spkl.io/6048f8XxQ
-
🔬 Science has the power to transform lives, but it's the human stories that truly drive innovation. At Roche’s new pRED Innovation Center in Basel, researchers like Jens Barthold and Isabel Bachmeier are inspired by personal experiences, blending passion with cutting-edge science to solve society's toughest health challenges. Whether it’s finding a cure for Alzheimer’s or developing life-saving cancer treatments, collaboration is key. Learn how we’re breaking boundaries in healthcare—join the movement toward better solutions for patients worldwide. 🌍 Click to explore: http://spkl.io/6049f8RXF